2012 | Aarkstore.com | Intel genx corp. – product pipeline review – 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
IntelGenx Corp. – Product Pipeline Review – 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s pharmaceuticals report, “IntelGenx Corp. - Product Pipeline
Review - 2012” provides data on the IntelGenx Corp.’s research and development
focus. The report includes information on current developmental pipeline, complete
with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, IntelGenx Corp.’s corporate website, SEC filings, investor
presentations and featured press releases, both from IntelGenx Corp. and industry-
specific third party sources, put together by Global Markets Direct’s team.
Scope
- IntelGenx Corp. - Brief IntelGenx Corp. overview including business description,
key information and facts, and its locations and subsidiaries.
- Review of current pipeline of IntelGenx Corp. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
Reasons to buy
- Evaluate IntelGenx Corp.’s strategic position with total access to detailed
information on its product pipeline.
- Assess the growth potential of IntelGenx Corp. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the IntelGenx Corp.’s R&D

2. portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
Table of contents:
List of Tables 4
List of Figures 5
IntelGenx Corp. Snapshot 6
IntelGenx Corp. Overview 6
Key Information 6
Key Facts 6
IntelGenx Corp. – Research and Development Overview 7
Key Therapeutic Areas 7
IntelGenx Corp. – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
IntelGenx Corp. – Pipeline Products Glance 11
IntelGenx Corp. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
IntelGenx Corp. – Early Stage Pipeline Products 13
Pre-Clinical Products/Combination Treatment Modalities 13
IntelGenx Corp. – Drug Profiles 14
INT-0007 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
INT-0008 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
INT-0020 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
INT-0022 17
Product Description 17

3. Mechanism of Action 17
R&D Progress 17
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
HanAll Biopharma Co., Ltd. – Product Pipeline Review – 2012
Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012
IntelGenx Corp. – Product Pipeline Review – 2012
Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2012
JADO Technologies GmbH – Product Pipeline Review – 2012
Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2012
NeuroSearch A/S – Product Pipeline Review – 2012
NovaDel Pharma, Inc. – Product Pipeline Review – 2012

4. Portola Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com